Department of Population and Quantitative Health Sciences, UMass Chan Medical School, Worcester, Massachusetts.
Department of Medicine, UMass Chan Medical School, Worcester, Massachusetts.
Sci Diabetes Self Manag Care. 2024 Dec;50(6):497-509. doi: 10.1177/26350106241285829. Epub 2024 Oct 14.
The purpose of the study was to describe the development and feasibility of implementing the DM-BOOST program in support of an established diabetes self-management education and support (DSMES) program.
A patient panel of 4 adults with type 2 diabetes (T2DM) codesigned DM-BOOST. DM-BOOST is a patient-focused program that includes peer-written text messages about diabetes self-management behaviors and digital health training to improve patient portal use and initiate goal setting prior to a scheduled DSMES appointment. Adults with T2DM and A1C ≥8.0% participated in a 6-month feasibility pilot. Participants were randomly assigned (1:1) to receive either DM-BOOST or usual care. Outcomes included DSMES engagement (scheduled and attended DSMES appointments) and changes in diabetes self-efficacy and treatment satisfaction.
Pilot participants (n = 60) were 60.0% female with mean age 45.5 years (SD 8.3) and A1C 10.1% (SD 1.8%). All DM-BOOST participants (30/30, 100%) had DSMES appointments scheduled compared to 86.7% of usual care (26/30). DM-BOOST participants had fewer DSMES appointment no-shows/cancellations (3/30, 10%) compared to usual care (10/26, 35%). There was greater improvement in diabetes self-efficacy in the DM-BOOST group compared to usual care and no difference in treatment satisfaction.
DM-BOOST, leveraging peer-written text messaging and digital health training, increased DSMES engagement. Implementation of DM-BOOST was determined to be feasible, with several system-level barriers identified, including obtaining provider referrals and scheduling appointments. An effectiveness trial of DM-BOOST is needed to evaluate the impact on clinical outcomes.
本研究旨在描述 DM-BOOST 项目的开发和实施情况,以支持已建立的糖尿病自我管理教育和支持(DSMES)项目。
由 4 名 2 型糖尿病(T2DM)成年患者组成的患者小组共同设计了 DM-BOOST。DM-BOOST 是一个以患者为中心的项目,包括关于糖尿病自我管理行为的同行撰写的文本信息以及数字健康培训,以改善患者门户的使用并在预定的 DSMES 预约之前开始设定目标。A1C≥8.0%的 T2DM 成年患者参加了为期 6 个月的可行性试点研究。参与者被随机分配(1:1)接受 DM-BOOST 或常规护理。结果包括 DSMES 的参与情况(安排和参加 DSMES 预约)以及糖尿病自我效能和治疗满意度的变化。
试点参与者(n=60)中 60.0%为女性,平均年龄为 45.5 岁(SD 8.3),A1C 为 10.1%(SD 1.8%)。所有 DM-BOOST 参与者(30/30,100%)都预约了 DSMES 就诊,而常规护理组为 86.7%(26/30)。与常规护理组(10/26,35%)相比,DM-BOOST 组的 DSMES 预约缺席/取消率(3/30,10%)较低。与常规护理相比,DM-BOOST 组的糖尿病自我效能感有更大的提高,而治疗满意度没有差异。
DM-BOOST 通过利用同行撰写的文本信息和数字健康培训,增加了 DSMES 的参与度。DM-BOOST 的实施被确定是可行的,但也发现了一些系统层面的障碍,包括获得提供者的转介和安排预约。需要进行 DM-BOOST 的有效性试验,以评估其对临床结果的影响。